期刊文献+

克白颗粒抗白癜风的体内外药效研究 被引量:4

Anti-vitiligo Effects of Kebai Particles on Leucoderma in Vitro and in Vivo
原文传递
导出
摘要 目的研究克白颗粒抗白癜风的体内外药效,并对克白颗粒进行安全性评价。方法采用血清药理学实验方法检测克白颗粒含药血清对小鼠黑色素瘤细胞B16f10增殖能力的影响;选取50只健康豚鼠随机分成正常对照组、模型对照组及克白颗粒高、中、低剂量(9.04,4.52,2.26 g·kg?1·d?1)组,每组10只,除正常对照组外,其余各组采用化学脱色法连续涂抹7%H2O2 50 d,制备实验性白癜风豚鼠模型,肉眼观察各给药组对实验性白癜风豚鼠模型的疗效,检测豚鼠血液中酪氨酸酶(TRY)、胆碱酯酶(CHE)、单胺氧化酶(MAO)、丙二醛(MDA)的含量;长期毒性实验对克白颗粒进行安全性评价。结果血清药理学实验表明克白颗粒含药血清能够显著促进B16f10细胞的体外增殖。造模后,模型组豚鼠血清MDA、MAO含量显著升高(P<0.05),CHE、TRY含量显著降低(P<0.05或0.01);与模型对照组比较,克白颗粒高剂量显著降低血清中MDA含量(P<0.01),高、中剂量显著降低MAO的含量(P<0.05)、显著升高CHE的含量(P<0.05),但对TRY含量无显著影响。长期毒性实验结果显示克白颗粒对SD大鼠脏器重量无显著影响。结论克白颗粒显示出良好的抗白癜风效果,其作用机制可能与调节血液中CHE、MAO、MDA含量、促进黑色素细胞增殖有关。 OBJECTIVE To explore the anti-vitiligo effects of Kebai particles in vitro and in vivo and evaluate the safety of Kebai particles. METHODS The effects of Kebai particles on mouse melanoma cells B16f10 proliferation in vitro was tested by serum pharmacology method. Long term toxicity test were carried out to evaluate the safety of Kebai particles. 50 guinea pigs were randomly divided into 5 groups: normal control group, model control group, high, middle and low dose group of Kebai particles(9.04,4.52,2.26 g·kg^-1·d^-1). The experimental vitiligo guinea pig model was prepared by 7% H2O2 for 50 d. Melanin distribution in skin and cholinesterase(CHE), monoamine oxidase(MAO), malondialdehyde(MDA) and tyrosinase(TYR) in blood were determined. RESULTS The results of serum pharmacology experiment showed that medicated serum significantly promoted the proliferation of B16f10 cells in vitro. Long-term toxicity experiment results indicated Kebai particles exhibited no effect on viscera weight of SD rats. Animal experimental data showed that the serum level of MAO and MDA significantly increased in model control group(P〈0.05), while the serum level of CHE and TRY significantly decreased in model control group(P〈0.01 or 0.05). Compared with the model control group, high dose of Kebai particles significantly decreased the serum content of MDA(P〈0.01), high and middle dose of Kebai particles significantly decreased the content of MAO and increased the content of CHE(P〈0.05). CONCLUSION Kebai particles show good anti-vitiligo effects, its main mechanism may be related to decrease the contents of serum CHE, MAO and MDA and promote the proliferation of melanocytes.
出处 《中国现代应用药学》 CAS CSCD 2015年第9期1046-1050,共5页 Chinese Journal of Modern Applied Pharmacy
基金 浙江省中西医结合学会科研基金项目(2013LYZD019)
关键词 克白颗粒 白癜风 血清药理学 动物模型 Kebai particles vitiligo serum pharmacology methods animal model
  • 相关文献

参考文献10

二级参考文献49

  • 1王飞,徐汉卿.白癜风患者血清及皮损中某些酶及微量元素改变研究[J].中国皮肤性病学杂志,1993,7(3):142-143. 被引量:11
  • 2林晓,傅雯雯.皮肤外用他克莫司治疗白癜风[J].国际皮肤性病学杂志,2006,32(4):205-207. 被引量:7
  • 3张继玲,曹碧兰.白癜风免疫学说新进展[J].遵义医学院学报,2006,29(4):403-407. 被引量:8
  • 4朱其贵 方步武 等.牛血清蛋白致免疫性肝纤维化动物模型的研究[J].中华病理杂志,1993,22(2):121-121. 被引量:1
  • 5Lotti T, Gori A, Zanieri F, et al. Vitiligo: new and emerging treat- ments. Dermatol Ther, 2008, 21 ( 2 ): 110- 117. 被引量:1
  • 6Hirobe T. Role of keratinoeyte-derived factors involved in regulating the proliferation and differentiation of mammalian epidermal melanocytes. Pigment Cell Res, 2005, 18(1 ): 2-12. 被引量:1
  • 7Hautmann G, Panconesi E. Vitiligo: a psychologically influenced and influencing disease[J]. Clin Dermatol, 1997,15: 879-890. 被引量:1
  • 8Firooz A, Bouzari N, Fallah N, et al. What patients with vitiligo believe about their condition[J]. Int J Dermatol,2004,43:811-814. 被引量:1
  • 9Ongenae K, Van Geel N, De Schepper S, et al. Effect of vitiligo on self-reported health-related quality of life[J]. Br J Dermatol, 2005, 152:1165-1172. 被引量:1
  • 10Le Guay JL. How you can help the vitiligo patient[J]. Med Today,2000, 12:36-45. 被引量:1

共引文献112

同被引文献45

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部